TrustCore Financial Services’s TG Therapeutics TGTX Stock Holding History

TrustCore Financial Services’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$4.73K	Buy	+400	New	+$2.9K	﹤0.01%	832
2022 Q3	–	Sell	-600	Closed	-$3K	–	1170
2022 Q2	$3K	Buy	600 +100	+20%	+$624	﹤0.01%	919
2022 Q1	$5K	Buy	500 +200	+67%	+$2.31K	﹤0.01%	865
2021 Q4	$6K	Buy	300 +50	+20%	+$1.3K	﹤0.01%	774
2021 Q3	$8K	Buy	250 +115	+85%	+$3.56K	﹤0.01%	804
2021 Q2	$5K	Buy	135 +13	+11%	+$511	﹤0.01%	852
2021 Q1	$6K	Hold	122	–	–	﹤0.01%	771
2020 Q4	$6K	Buy	+122	New	+$4.12K	﹤0.01%	751

Other funds holding TGTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

TrustCore Financial Services's TGTX Position: Q4 2022 in Review

TrustCore Financial Services opened a new position in TG Therapeutics (TGTX) in Q4 2022: 400 shares worth $4.73K. The stake represents ﹤0.01% of the portfolio and ranks #832 among its holdings. This is a return to the name: TrustCore Financial Services previously reported a position in TGTX as recently as Q2 2022.

TrustCore Financial Services first reported a position in TGTX in Q4 2020 and has held it in 8 quarters since. The position peaked at $8K in Q3 2021. 197 funds tracked by Wall St. Rank hold TGTX as of Q4 2022.

TrustCore Financial Services held 400 shares of TG Therapeutics worth $4.73K as of Q4 2022.
TG Therapeutics was a new TrustCore Financial Services position in Q4 2022.
TG Therapeutics made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #832 holding.
TrustCore Financial Services first reported a position in TG Therapeutics in Q4 2020 and has held it in 8 quarters since.
TrustCore Financial Services's TG Therapeutics position peaked at $8K in Q3 2021.
197 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.